Cargando…

DEVELOPMENT OF LABORATORY AND POINT OF CARE DETECTION PLATFORMS FOR COVID-19 NEUTRALIZING ANTIBODIES AND IMMUNE STATUS

INTRO: Neutralizing antibody responses, including the omicron and other variants targeting SARS-CoV-2, are important serological parameter that may predict protective immunity for COVI-19. This protection status may have a direct impact on the response to this virus including vaccination and protect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trudil, D., Loomis, L., MacAry, P., Almond, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186883/ http://dx.doi.org/10.1016/j.ijid.2023.04.224

Ejemplares similares

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
por: Kongsuphol, Patthara, et al.
Publicado: (2021)

Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting
por: Lim, Hui Xuan, et al.
Publicado: (2022)

A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2017)

Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus
por: Jhajharia, Saket, et al.
Publicado: (2022)

Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2018)

Defining neutralization and allostery by antibodies against COVID-19 variants
por: Tulsian, Nikhil Kumar, et al.
Publicado: (2023)

SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture
por: Malisheni, Moffat M., et al.
Publicado: (2022)

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
por: Murji, Amyn A., et al.
Publicado: (2021)

High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles
por: Lücke, Arlen-Celina, et al.
Publicado: (2022)

The trinity of COVID-19: immunity, inflammation and intervention
por: Tay, Matthew Zirui, et al.
Publicado: (2020)

The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective
por: Lim, She Yah, et al.
Publicado: (2015)

Detection of Neutralizing Antibodies to Tembusu Virus: Implications for Infection and Immunity
por: Lv, Junfeng, et al.
Publicado: (2019)

Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2
por: Lake, Douglas F., et al.
Publicado: (2021)

Optimized Expression of Full-Length IgG1 Antibody in a Common E. coli Strain
por: Chan, Conrad En Zuo, et al.
Publicado: (2010)

Correlation of In-situ Hand Anatomy With Point of Care Ultrasound
por: Loomis, Mario, et al.
Publicado: (2023)

Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
por: Connelly, Guinevere G., et al.
Publicado: (2022)

RHEA pilot platform
por: Loomis, Charles
Publicado: (2018)

Pleiotropic Effects of Blastocystis spp. Subtypes 4 and 7 on Ligand-Specific Toll-Like Receptor Signaling and NF-κB Activation in a Human Monocyte Cell Line
por: Teo, Joshua D. W., et al.
Publicado: (2014)

Finger stick blood test to assess postvaccination SARS‐CoV‐2 neutralizing antibody response against variants
por: Lim, Sing Mei, et al.
Publicado: (2022)

Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting
por: McCance, Kirsty, et al.
Publicado: (2022)

Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies
por: Malisheni, Moffat M., et al.
Publicado: (2022)

Human Milk Antibodies after BNT162b2 Vaccination Exhibit Reduced Binding against SARS-CoV-2 Variants of Concern
por: Low, Jia Ming, et al.
Publicado: (2022)

Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test
por: Chan, Michele Mun Hei, et al.
Publicado: (2022)

Hydrogen Sulfide and Neurogenic Inflammation in Polymicrobial Sepsis: Involvement of Substance P and ERK-NF-κB Signaling
por: Ang, Seah-Fang, et al.
Publicado: (2011)

Evaluation of point of care testing platform (ePLEX) for respiratory viral diagnosis
por: Guerendiain, Daniel, et al.
Publicado: (2016)

Neutralizing antibodies to HIV-1 induced by immunization
por: McCoy, Laura E., et al.
Publicado: (2013)

Virus Detection: From State‐of‐the‐Art Laboratories to Smartphone‐Based Point‐of‐Care Testing
por: Xiao, Meng, et al.
Publicado: (2022)

A monolithic single-chip point-of-care platform for metabolomic prostate cancer detection
por: Annese, Valerio F., et al.
Publicado: (2021)

Evaluation of Optical Detection Platforms for Multiplexed Detection of Proteins and the Need for Point-of-Care Biosensors for Clinical Use
por: Spindel, Samantha, et al.
Publicado: (2014)

A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection
por: McCarthy, Elizabeth E., et al.
Publicado: (2022)

The molecular basis for dysfunctional bacterial lipopolysaccharide-mediated immune receptor activation by SARS-CoV-2 spike
por: Samsudin, Firdaus, et al.
Publicado: (2023)

Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic Point-of-Care Setting Compared With an Established Laboratory Reference Method
por: Tait, Robert Campbell, et al.
Publicado: (2019)

Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world
por: Li, Min, et al.
Publicado: (2022)

Potential of Point-of-Care and At-Home Assessment of Immune Status via Rapid Cytokine Detection and Questionnaire-Based Anamnesis
por: Jamaludeen, Noor, et al.
Publicado: (2021)

Analysis of Factors Affecting Neutralizing Antibody Production after COVID-19 Vaccination Using Newly Developed Rapid Point-of-Care Test
por: Shim, Hyeon Woo, et al.
Publicado: (2022)

A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies
por: Chen, Xun, et al.
Publicado: (2020)

A Detection-Service-Mobile Three-Terminal Software Platform for Point-of-Care Infectious Disease Detection System
por: Su, Xiangyi, et al.
Publicado: (2022)

Laboratory-Based and Point-of-Care Testing for MSSA/MRSA Detection in the Age of Whole Genome Sequencing
por: van Belkum, Alex, et al.
Publicado: (2018)

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022)

The other side of the coin: Leveraging Epstein–Barr virus in research and therapy
por: Yu, Fenggang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ekp5ge0he3238lvi6iedc8t2ck